Antianxiety actions of Ca2+ channel antagonists with Vogel-type conflict test in rats. 1994

Y Matsumoto, and Y Kataoka, and Y Watanabe, and A Miyazaki, and K Taniyama
Department of Pharmacology, School Nurse Training, Kyushu Women's Jr. College, Japan.

We examined the effects of various derivatives of Ca2+ channel antagonists in a modified rat Vogel-type conflict model. Flunarizine (10 and 20 mg/kg), nicardipine (20 mg/kg), and verapamil (20 mg/kg), given as single i.p. injections, significantly increased punished lickings by 50-110%. Chronic administration of diltiazem, at 20 mg/kg i.p. for 8 days, a dose ineffective with a single i.p. injection, produced a significant anticonflict action. The possibility that Ca2+ channel antagonists have anxiolytic action should be considered.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008297 Male Males
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D004558 Electric Stimulation Use of electric potential or currents to elicit biological responses. Stimulation, Electric,Electrical Stimulation,Electric Stimulations,Electrical Stimulations,Stimulation, Electrical,Stimulations, Electric,Stimulations, Electrical
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001007 Anxiety Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS. Angst,Anxiousness,Hypervigilance,Nervousness,Social Anxiety,Anxieties, Social,Anxiety, Social,Social Anxieties
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Y Matsumoto, and Y Kataoka, and Y Watanabe, and A Miyazaki, and K Taniyama
December 1998, Neuropharmacology,
Y Matsumoto, and Y Kataoka, and Y Watanabe, and A Miyazaki, and K Taniyama
November 1988, Trends in pharmacological sciences,
Y Matsumoto, and Y Kataoka, and Y Watanabe, and A Miyazaki, and K Taniyama
January 1990, Trends in pharmacological sciences,
Y Matsumoto, and Y Kataoka, and Y Watanabe, and A Miyazaki, and K Taniyama
June 1999, Japanese journal of pharmacology,
Y Matsumoto, and Y Kataoka, and Y Watanabe, and A Miyazaki, and K Taniyama
December 2006, Progress in neuro-psychopharmacology & biological psychiatry,
Y Matsumoto, and Y Kataoka, and Y Watanabe, and A Miyazaki, and K Taniyama
August 1995, Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology,
Y Matsumoto, and Y Kataoka, and Y Watanabe, and A Miyazaki, and K Taniyama
February 1993, Brain research,
Y Matsumoto, and Y Kataoka, and Y Watanabe, and A Miyazaki, and K Taniyama
November 2007, Neuropharmacology,
Y Matsumoto, and Y Kataoka, and Y Watanabe, and A Miyazaki, and K Taniyama
May 1992, Japanese journal of pharmacology,
Y Matsumoto, and Y Kataoka, and Y Watanabe, and A Miyazaki, and K Taniyama
March 2011, Behavioural brain research,
Copied contents to your clipboard!